Delivery Order SPE2DB25D3404-SPE2DB25FUPNS
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 1, 2025, for the supply of Progesterone 200 mg capsules (100-count units) with a ceiling value of $32,993.69. This is a firm fixed-price delivery order with an ultimate completion date of August 4, 2025, and represents a non-set-aside award made through competitive procurement. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform this...
- The Defense Logistics Agency awarded a delivery order valued at $9,242.11 to AmerisourceBergen Drug Corp for Progesterone 200 mg capsules (100-count units) on July 28, 2025, with an ultimate completion date of July 29, 2025. This firm fixed-price delivery order was competitively awarded without a set-aside designation and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and critical...
- The Defense Logistics Agency awarded a delivery order valued at $14,740.75 to AmerisourceBergen Drug Corp for Progesterone 200 mg capsules (100-count units) on July 22, 2025, with an ultimate completion date of July 23, 2025. This firm fixed price delivery order represents a non-competitive set-aside award and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions...
- The Defense Logistics Agency awarded a delivery order valued at $16,351.09 to AmerisourceBergen Drug Corp for the supply of Progesterone 200 mg capsules (100-count units). This firm fixed-price delivery order, executed on July 31, 2025, is scheduled for completion by August 1, 2025, with performance to be fulfilled at the vendor's corporate office location in Conshohocken, Pennsylvania. The award was made through open competition with no set-aside designation applied. This delivery order is...
- The Defense Logistics Agency awarded a $4,310.34 delivery order to AmerisourceBergen Drug Corp for Progesterone 200 mg capsules (100-count units) under a firm fixed price contract. This delivery order, issued on July 23, 2025, with an ultimate completion date of July 24, 2025, represents a small-value transaction for pharmaceutical supply to support federal medical procurement needs. The award was made on a non-set-aside, competitive basis, with performance occurring at the contractor's...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 4, 2025, for the supply of Progesterone 200 mg capsules (100 count) under a firm fixed-price contract valued at $3,439.80. This non-set-aside delivery order will be completed by August 5, 2025, with performance at the vendor's corporate office location in Conshohocken, Pennsylvania. The award represents a continuation of AmerisourceBergen's critical role as a pharmaceutical supplier supporting...
- The Defense Logistics Agency awarded a $1,152.00 delivery order to AmerisourceBergen Drug Corp for Progesterone 100 mg capsules (100-count) on July 30, 2025, with a completion date of July 31, 2025. This is a firm fixed price, non-set-aside contract performed at AmerisourceBergen's facility in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $999,999,999.00...
- The Defense Logistics Agency awarded a $2,170.85 firm fixed price delivery order to AmerisourceBergen Drug Corp for Progesterone 100 mg capsules (30-count units) on August 8, 2025, with an ultimate completion date of August 11, 2025. This non-set-aside competitive award represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.999 billion comprehensive pharmaceutical prime vendor agreement running through...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 28, 2025, for the supply of Progesterone 200 mg capsules (100-count units) with a contract ceiling value of $25,285.45. This firm fixed-price delivery order, which carries an ultimate completion date of July 29, 2025, represents a non-competitive set-aside award and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 5, 2025, for the supply of Progesterone 200 mg capsules in quantities of 30 units. This firm fixed-price delivery order, valued at $7,627.49, represents a non-competitive set-aside award and is scheduled for completion by August 6, 2025. The pharmaceutical product will be delivered from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, supporting the Defense Department's...
- SPE2DB25D3404Indefinite Delivery Contract
- SPE2DB25D3404-SPE2DB25FUPNSDelivery Order
The Defense Logistics Agency awarded a $3,125.26 delivery order to AmerisourceBergen Drug Corp for the supply of Progesterone 200 mg capsules (100 count) under a firm fixed-price contract type. The order, issued on August 1, 2025, with an ultimate completion date of August 4, 2025, represents a direct procurement with no set-aside designation. Performance will be executed at the contractor's facility in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated as SPE2DX, which is valued at $999,999,999.00 and extends through December 2026. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider headquartered in Pennsylvania, serves as a critical vendor for federal medical procurement, particularly supporting military and veteran healthcare systems. The company's SPE2DX IDC functions as a comprehensive global pharmaceutical support vehicle enabling the supply of a broad range of pharmaceutical products and medical supplies to support military healthcare programs worldwide. This delivery order exemplifies the company's role in fulfilling federal medical supply requirements through open competition, with the contract supporting Defense Health Agency operations and other government healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $3.1k | 8/1/25 |